The agency also assigned an “AA-” long-term rating to the health system’s $2.1 billion of series 2017 fixed-rate taxable revenue bonds and its $300 million of series 2017 floating-rate notes.
S&P also affirmed the “AA-/A-1+” dual rating on Kaiser’s existing debt.
“The rating assignment and affirmation reflects Kaiser Permanente’s very strong and improving enterprise profile reflecting a favorable integrated business model and strong membership growth over the past three years,” said S&P analyst Martin Arrick.
The outlook is stable, reflecting S&P Global Rating’s view of the health system’s strong enterprise profile, growing membership and strong financial operations.
More articles on healthcare finance:
CMS’ 2018 IPPS proposed rule: 9 things to know
7 recent RCM hires
For-profit hospital stock report: Week of April 10-14
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
